v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
OPERATING ACTIVITIES    
Net loss $ (23,047) $ (53,698)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Share-based compensation expense 8,033 7,165
Depreciation and amortization expense, including amortization of deferred financing costs 47,190 49,451
Deferred rent (788) (837)
Loss from unconsolidated real estate ventures, net 374 592
Amortization (accretion) of market lease intangibles, net 82 (69)
Amortization of lease incentives 571 3,865
Loss on the extinguishment of debt, net   4,636
Impairment loss 1,500 8,483
Gain on the sale of real estate, net (21,075) (537)
Loss on operating lease and other receivables 154 706
(Income) loss from investments, net (140) 438
Return on capital from unconsolidated real estate ventures 594 390
Other non-cash items (156) 1,308
Changes in operating assets and liabilities:    
Tenant and other receivables (5,423) 1,674
Other assets, net (1,140) (1,830)
Accounts payable and accrued expenses (2,870) (7,482)
Other liabilities, net (450) (1,320)
Net cash provided by operating activities 3,409 12,935
INVESTING ACTIVITIES    
Development costs, construction in progress and real estate additions (23,236) (29,091)
Proceeds from the sale of real estate 46,582 188,779
Proceeds from derivative financial instruments 1,879 2,537
Distributions of capital from unconsolidated real estate ventures and other investments   465
Investments in unconsolidated real estate ventures and other investments (1,234) (1,376)
Net cash provided by investing activities 23,991 161,314
FINANCING ACTIVITIES    
Borrowings under mortgage loans 1,595 265,205
Borrowings under revolving credit facility 60,000 197,000
Repayments of mortgage loans (1,548) (408,040)
Repayments of revolving credit facility (35,000) (120,000)
Payments on derivative financial instruments (818) (1,104)
Debt issuance and modification costs (270) (5,207)
Redemption of noncontrolling interests (777)  
Proceeds from common shares issued pursuant to ESPP 238 244
Common shares repurchased (25,401) (147,593)
Dividends paid to common shareholders (10,417) (14,788)
Distributions to redeemable noncontrolling interests (3,437) (2,823)
Net cash used in financing activities (15,835) (237,106)
Net increase (decrease) in cash and cash equivalents, and restricted cash 11,565 (62,857)
Cash and cash equivalents, and restricted cash, beginning of period 103,290 183,192
Cash and cash equivalents, and restricted cash, end of period 114,855 120,335
SUPPLEMENTAL DISCLOSURE OF CASH FLOW AND NON-CASH INFORMATION    
Cash paid for interest (net of capitalized interest of $400 and $998 in 2026 and 2025) 32,523 32,653
Accrued capital expenditures 27,976 40,768
Write-off of fully depreciated assets 6,224 11,954
Cash paid for income taxes 7 85
Redemption of OP Units for common shares 7,825 9,719
Redeemable noncontrolling interests redemption value adjustment (14,920) 5,951
Accrual for common shares repurchased pending settlement   40,142
Cash paid for amounts included in the measurement of lease liabilities for operating leases $ 1,356 $ 1,664